
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging Ltd has reported an increase in quarterly revenue to $3.4 million, a notable rise from $3.0 million in the prior quarter, primarily driven by enhanced teleradiology utilization and improved margins. The company has reaffirmed its deployment goal of exceeding 100 units globally by year-end and has issued a revenue guidance of $35 million for 2026, reflecting anticipated growth and confidence in their business model. Additionally, a strategic partnership with 3DR Labs enhances the distribution of its AI imaging solutions to over 1,800 hospitals, thereby expanding its market presence and promoting early disease detection, which could further bolster revenue streams.
Bears say
Nano X Imaging Ltd reported a significant decrease in cash reserves, dropping to $55.5 million from $83.2 million, primarily due to an operating cash burn of $30.4 million. The company has consistently lowered its expectations for revenue growth, indicating potential challenges in achieving financial targets. Additionally, the elevated GAAP gross loss of $2.9 million, combined with a stable net loss of $13.7 million, underscores ongoing financial pressures tied to investments in system deployments and AI infrastructure.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares